Collins Helen Louise 4
4 · Enliven Therapeutics, Inc. · Filed Feb 10, 2025
Insider Transaction Report
Form 4
Collins Helen Louise
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2025-02-06+171,000→ 171,000 totalExercise: $22.47Exp: 2035-02-06→ Common Stock (171,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option will vest on February 6, 2026 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.